iSpecimen Inc. (ISPC)
USD 1.27
(-3.79%)
USD 1.27
(-3.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.16 Million USD | -9.65% |
| 2022 | -10.18 Million USD | -71.91% |
| 2021 | -5.92 Million USD | -146.23% |
| 2020 | -2.4 Million USD | 37.98% |
| 2019 | -3.88 Million USD | -15.61% |
| 2018 | -3.35 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.18 Million USD | 27.29% |
| 2024 Q1 | -3 Million USD | -4.51% |
| 2023 Q4 | -2.87 Million USD | -30.85% |
| 2023 FY | -11.16 Million USD | -9.65% |
| 2023 Q3 | -2.19 Million USD | 38.4% |
| 2023 Q2 | -3.56 Million USD | -40.1% |
| 2023 Q1 | -2.54 Million USD | -18.71% |
| 2022 Q2 | -2.58 Million USD | -9.61% |
| 2022 Q1 | -2.35 Million USD | -18.22% |
| 2022 Q3 | -3.1 Million USD | -19.96% |
| 2022 FY | -10.18 Million USD | -71.91% |
| 2022 Q4 | -2.14 Million USD | 30.94% |
| 2021 Q2 | -1.52 Million USD | -62.15% |
| 2021 FY | -5.92 Million USD | -146.23% |
| 2021 Q1 | -942.64 Thousand USD | -0.88% |
| 2021 Q4 | -1.99 Million USD | -36.73% |
| 2021 Q3 | -1.45 Million USD | 4.54% |
| 2020 Q4 | -934.45 Thousand USD | -29.26% |
| 2020 FY | -2.4 Million USD | 37.98% |
| 2020 Q3 | -722.93 Thousand USD | -137.02% |
| 2020 Q2 | -305 Thousand USD | 31.54% |
| 2020 Q1 | -445.53 Thousand USD | 37.89% |
| 2019 FY | -3.88 Million USD | -15.61% |
| 2019 Q3 | -1.53 Million USD | 0.0% |
| 2019 Q4 | -717.29 Thousand USD | 53.2% |
| 2018 FY | -3.35 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 88.527% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -1.973% |
| Aspira Women's Health Inc. | -18.85 Million USD | 40.752% |
| Biodesix, Inc. | -41.34 Million USD | 72.983% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -330.652% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -40.086% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -40.086% |
| Bionano Genomics, Inc. | -215.24 Million USD | 94.811% |
| CareDx, Inc | -101.9 Million USD | 89.039% |
| Check-Cap Ltd. | -19.28 Million USD | 42.089% |
| Castle Biosciences, Inc. | -67.97 Million USD | 83.569% |
| DarioHealth Corp. | -56.18 Million USD | 80.122% |
| Exact Sciences Corporation | -215.01 Million USD | 94.805% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 84.635% |
| Guardant Health, Inc. | -564.72 Million USD | 98.022% |
| ICON Public Limited Company | 956.15 Million USD | 101.168% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 101.018% |
| Illumina, Inc. | -1.06 Billion USD | 98.955% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -8.618% |
| Standard BioTools Inc. | -76.6 Million USD | 85.419% |
| MDxHealth SA | -27.32 Million USD | 59.127% |
| 23andMe Holding Co. | -321.35 Million USD | 96.524% |
| Medpace Holdings, Inc. | 336.82 Million USD | 103.316% |
| Myriad Genetics, Inc. | -123.7 Million USD | 90.971% |
| Mainz Biomed B.V. | -26.64 Million USD | 58.08% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -6.165% |
| NeoGenomics, Inc. | -107.73 Million USD | 89.633% |
| Neogen Corporation | 58.66 Million USD | 119.04% |
| Inotiv, Inc. | -81.46 Million USD | 86.289% |
| Natera, Inc. | -446.24 Million USD | 97.497% |
| OpGen, Inc. | -15.68 Million USD | 28.805% |
| OPKO Health, Inc. | -157.02 Million USD | 92.887% |
| Psychemedics Corporation | -2.92 Million USD | -282.381% |
| Prenetics Global Limited | -52.51 Million USD | 78.731% |
| Prenetics Global Limited | -52.51 Million USD | 78.731% |
| Precipio, Inc. | -7.62 Million USD | -46.579% |
| Personalis, Inc. | -109.93 Million USD | 89.84% |
| RadNet, Inc. | 98.69 Million USD | 111.317% |
| Sera Prognostics, Inc. | -39.82 Million USD | 71.951% |
| Sotera Health Company | 276.69 Million USD | 104.037% |
| Neuronetics, Inc. | -30.55 Million USD | 63.444% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -157.003% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -157.003% |
| Trinity Biotech plc | -27.04 Million USD | 58.701% |
| T2 Biosystems, Inc. | -49.66 Million USD | 77.51% |
| Twist Bioscience Corporation | -220.83 Million USD | 94.942% |
| Exagen Inc. | -22.83 Million USD | 51.091% |